# Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)

> **NCT02388750** · PHASE2 · COMPLETED · sponsor: **Dr. Edward Chow** · enrollment: 96 (actual)

## Conditions studied

- Nausea
- Vomiting

## Interventions

- **DRUG:** Palonosetron
- **RADIATION:** Low or moderate risk radiotherapy

## Key facts

- **NCT ID:** NCT02388750
- **Lead sponsor:** Dr. Edward Chow
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-08-07
- **Final completion:** 2017-08-07
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02388750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02388750, "Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02388750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*